← Back to TCM Global · All articles

Pharma Giants Enter Ginseng: China Resources Joins the Processing Boom

pharma giants enter ginseng processing

2026-10-21

When Big Pharma Moves In

A telling marker of an industry's maturity: when pharmaceutical giants start building in your county. Jilin China Resources Heshantang Ginseng Co. — a wholly owned subsidiary of China Resources Sanjiu, one of China's largest pharma groups — now operates GMP- and SC-certified workshops in Fusong County.

What the Giant Is Building

Why Pharma-Grade Matters

GMP (Good Manufacturing Practice) certification brings pharmaceutical discipline to a product category that historically ranged from artisanal to opaque:

For consumers, "GMP workshop" on a ginseng label carries the same reassurance it does on a medicine label.

The Cluster Effect

Heshantang anchors its sourcing to the Wanliang market platform, citing stable supply and stable sales. Around it, Fusong counts 3,200+ registered ginseng businesses, 12 ginseng-pharma above-scale enterprises, and 9 GMP-certified decoction and cosmetic production facilities.

Reading the Signal

Pharma entry does three things to a botanical category:

  1. Raises the quality floor — small producers must meet higher specs to stay in the chain
  2. Legitimizes claims — drug-company involvement rebates credibility to the whole category
  3. Pre-figures regulation — the standards giants write today tend to become the industry's tomorrow
  4. The Takeaway

    The ginseng industry is consolidating toward pharmaceutical discipline — in the county with the most to gain from trust. Expect more "pharma-grade" language on ginseng products, and expect it to be verifiable.

    Explore more Eastern wellness wisdom at TCM Global.